Hepatitis Co-Infections in HIV Patients in Tanzania
Author Information
Author(s): Nagu Tumaini J, Bakari Muhammad, Matee Mecky
Primary Institution: Muhimbili University of Health and Allied Sciences
Hypothesis
What is the prevalence and predictors of viral hepatitis co-infection among HIV-infected individuals in Tanzania?
Conclusion
There is a high prevalence of hepatitis B and C infections among HIV-infected patients seeking care in Tanzania, indicating the need for routine screening.
Supporting Evidence
- The prevalence of hepatitis B and C infections was found to be 17.3% and 18.1%, respectively.
- Most patients with hepatitis co-infection showed no specific clinical features.
- History of blood transfusion and jaundice were identified as independent predictors for hepatitis co-infections.
Takeaway
Many people with HIV in Tanzania also have hepatitis B or C, which can make their treatment more complicated. It's important to check for these infections.
Methodology
A cross-sectional study was conducted with clinical assessments and serology tests for hepatitis markers among HIV-1 infected patients.
Potential Biases
Potential selection bias as participants were recruited from a specific hospital setting.
Limitations
The study may not represent all HIV-infected individuals in Tanzania as it was conducted at a single hospital.
Participant Demographics
70% female, mean age 37.3 years, aged 18 and above.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI for seroprevalence of hepatitis markers
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website